Hugel
Leading South Korean biopharmaceutical company specializing in botulinum toxin products (Letybo/Botulax) and dermal fillers for aesthetic and therapeutic applications. Publicly traded on KOSDAQ.
Website
https://www.hugel.co.krLocation
Seoul, South Korea
Founded
2001
Categories
biotech, aesthetics, botulinum-toxin, dermal-fillers, public